Mereo BioPharma (MREO) Cash from Financing Activities (2023 - 2025)
Mereo BioPharma (MREO) reported Cash from Financing Activities of $39000.0 for Q4 2025, up 197.5% year-over-year from $13109.2 in Q4 2024, and up 129.1% quarter-over-quarter from -$134000.0 in Q2 2025.
Mereo BioPharma (MREO) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has 3 years of Cash from Financing Activities data on file, last reported at $39000.0 in Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $39000.0, up 197.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$95000.0 (down 100.2% YoY), and the FY2025 annual result was $327000.0, down 99.29% from the prior year.
- Cash from Financing Activities grew to $39000.0 in Q4 2025 per MREO's latest filing, from -$134000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $46.8 million in Q2 2024 and troughed at -$594000.0 in Q3 2024.
- A 3-year average of $7.8 million and a median of $39000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities tumbled 107.51% in 2024, then jumped 197.5% in 2025.
- A 3-year view of Cash from Financing Activities shows it stood at $7.9 million in 2023, then tumbled by 100.51% to -$40000.0 in 2024, then jumped by 197.5% to $39000.0 in 2025.
- Business Quant data shows MREO's Cash from Financing Activities at $39000.0 in Q4 2025, -$134000.0 in Q2 2025, and $422000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Jun 30, 2025 | -134,000.00 |
| Jun 30, 2025 | -134,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | -594,000.00 |
| Sep 30, 2024 | -594,000.00 |
| Jun 30, 2024 | 46.78 Mn |
| Jun 30, 2024 | 46.78 Mn |
| Sep 30, 2023 | 7.91 Mn |
| Sep 30, 2023 | 7.91 Mn |